Advanced Search
EurekAlert! Science News A service of the American Association for the Advancement of Science
EurekAlert! Science News A service of the American Association for the Advancement of Science
  • Home
  • News Releases
  • Multimedia
  • Meetings
  • Login
  • Register

Multimedia Images

Motion mode transition of the multimodal amphibious robot

Motion mode transition of the multimodal amphibious robot...Beijing Institute of Technology Press Co., Ltd

Short-term Physical Activity Reduces Metabolic-associated Steatohepatitis by Promoting the Degradation of Branched-chain Amino Acids in Skeletal Muscle

Short-term Physical Activity Reduces Metabolic-associated Steatohepatitis by Promoting the Degradation of Branched-chain...Xia & He Publishing Inc.

Chemicals of concern in plastics

Chemicals of concern in plasticsSwiss Federal Laboratories for Materials Science and Technology (Empa)

Correlation matrix of chronological age and DNA methylation algorithms of aging

Correlation matrix of chronological age and DNA methylation algorithms of aging...Tsinghua University Press

The experimental system

The experimental systemBeijing Institute of Technology Press Co., Ltd

University of Houston provost and archeologist Diane Chase in newly discovered tomb

University of Houston provost and archeologist Diane Chase in newly discovered tomb...University of Houston

Synthesis and structure of fluorinated polyimide (FPI) with pentafluorophenyl side group

Synthesis and structure of fluorinated polyimide (FPI) with pentafluorophenyl side group...Industrial Chemistry & Materials

Cover - July JNCCN

Cover - July JNCCNNational Comprehensive Cancer Network

Pietro Scilipoti, MD

Pietro Scilipoti, MDNational Comprehensive Cancer Network

Dr. Joan Massagué

Dr. Joan MassaguéMemorial Sloan Kettering Cancer Center

Dr. Joan Massagué Presenting at AACR

Dr. Joan Massagué Presenting at AACRMemorial Sloan Kettering Cancer Center

Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study

Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1...Elsevier

  • 297
  • 298
  • 299
  • 300
  • 301

EurekAlert! The Global Source for Science News

AAAS - American Association for the Advancement of Science

Copyright © 2025 by the American Association for the Advancement of Science (AAAS)

  • facebook.com/EurekAlert
  • @EurekAlert
  • youtube.com/EurekAlert

  • Help / FAQ
  • Services
  • Eligibility Guidelines
  • Contact EurekAlert!
  • Terms & Conditions
  • DMCA
  • Privacy Policy
  • Disclaimer

Copyright © 2025 by the American Association for the Advancement of Science (AAAS)